Watch Ticker

Novo-Nordisk A/S

Go to Novo-Nordisk A/S Website

$48.33

1.26 (2.68%)

Live

Previous Close

$48.19

Day Range

$47.55 - $49.03

Previous Day Range

$46.9 - $49.3

Market Cap

$214.1 billion USD

Day Vol.

34.8 million

Previous Day Vol.

50.4 million

Currency

USD

Primary Exchange

New York Stock Exchange

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, inject...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Robbins Geller Rudman & Dowd Llp - INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - HIMS

Hims & Hers Health is facing a class action lawsuit alleging deceptive promotion of Wegovy® medications, which led to Novo Nordisk terminating their partnership and causing a 34% stock price drop.

Related tickers: HIMS, NVO.

Read Full Article

Bleichmar Fonti & Auld Llp - HIMS LEGAL ALERT: Lose Money on Your Hims & Hers Health, Inc. Investment? Contact BFA Law by August 25 Class Action Deadline (NYSE:HIMS)

Hims & Hers Health is facing a securities fraud lawsuit alleging misrepresentation of its partnership with Novo Nordisk regarding weight loss drug Wegovy sales, resulting in significant stock price decline after partnership termination.

Related tickers: HIMS, NVO.

Read Full Article

Trending Tickers

Please sign in to view